Formic Acid

Formic Acid

SCHEMBL6715491

Cc1ccc(NC(=O)[C@H](N)c2ccccc2)cc1.O=CO

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
MAPT P10636 3/20 0.53
LMNA P02545 2/20 0.53
HTT P42858 2/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
HTR1E P28566 1/20 0.52
S1PR3 Q99500 1/20 0.52
CASR P41180 1/20 0.51
ROCK2 O75116 1/20 0.49
ROCK1 Q13464 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
BAZ1A Q9NRL2 1/20 0.48
POLB P06746 2/20 0.48
TAAR1 Q96RJ0 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HPN P05981 2/20 0.46
PLAU P00749 1/20 0.46
EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6717100 0.94 ALDH1A1 (0.63) ALDH1A1MAPTLMNAHTTKMT2A
SCHEMBL6717109 0.94 ALDH1A1 (0.63) ALDH1A1MAPTLMNAHTTKMT2A
Formic Acid SCHEMBL6713928 0.87 CRHBP (0.58) ALDH1A1MAPTLMNAHTTROCK2
SCHEMBL23611205 0.84 ROCK2 (0.56) ALDH1A1MAPTHTTKMT2AMEN1
SCHEMBL23611208 0.84 ROCK2 (0.56) ALDH1A1MAPTHTTKMT2AMEN1
SCHEMBL4982071 0.82 POLB (0.66) ALDH1A1MAPTLMNAHTTKMT2A
SCHEMBL19074543 0.82 POLB (0.66) ALDH1A1MAPTLMNAHTTKMT2A
Formic Acid SCHEMBL6722850 0.82 RAB9A (0.52) ALDH1A1MAPTHTTKMT2AMEN1
Dimethylamine SCHEMBL6726772 0.81 POLB (0.59) ALDH1A1MAPTLMNAKMT2AMEN1
Hydrochloric Acid SCHEMBL8010089 0.81 POLB (0.63) ALDH1A1MAPTLMNAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040152740-A1 Arylglycine derivatives for use as glycine transport inhibitors NPS ALLELIX CORPORATION (CA) 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152740-A1 Arylglycine derivatives for use as glycine transport inhibitors SLC1A2, SLC6A7, SLC1A1 ALDH1A1 572/4885MAPT 427/4885LMNA 3700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.